Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.70
-0.05 (-0.87%)
At close: Nov 22, 2024, 4:00 PM
5.80
+0.10 (1.75%)
After-hours: Nov 22, 2024, 7:59 PM EST
Recursion Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for RXRX stock have an average target of 9.25, with a low estimate of 6.00 and a high estimate of 12. The average target predicts an increase of 62.28% from the current stock price of 5.70.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for RXRX stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 2 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 4 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +92.98% | Nov 20, 2024 |
| Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +92.98% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Maintains $16 → $11 | Strong Buy | Maintains | $16 → $11 | +92.98% | Sep 4, 2024 |
| Jefferies | Jefferies | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +5.26% | Sep 3, 2024 |
| Leerink Partners | Leerink Partners | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | +40.35% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
67.17M
from 44.58M
Increased by 50.69%
Revenue Next Year
94.11M
from 67.17M
Increased by 40.10%
EPS This Year
-1.62
from -1.58
EPS Next Year
-1.79
from -1.62
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 92.7M | 267.7M | 218.4M |
| Avg | 67.2M | 94.1M | 128.4M |
| Low | 43.7M | 45.1M | 73.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 108.0% | 298.5% | 132.1% |
| Avg | 50.7% | 40.1% | 36.4% |
| Low | -1.9% | -32.9% | -21.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.52 | -1.32 | -1.12 |
| Avg | -1.62 | -1.79 | -1.46 |
| Low | -1.96 | -3.14 | -1.76 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.